ArticleFrontiers in immunology2023

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy.

De-Zhen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.